FDAer Resigns Over Plan B; Senators Seek Results Of GAO Investigation
This article was originally published in The Tan Sheet
Executive Summary
FDA Office of Women's Health Director Susan Wood is resigning over the agency's handling of Barr Labs' application to switch its Plan B emergency contraceptive over-the-counter
You may also be interested in...
FDA Sidelines Chief Spokesperson As It Grapples With Fallout From COVID-19 Plasma Authorization
Emily Miller, who joined FDA a few days before its controversial roll out of emergency use authorization for convalescent plasma, remains at the agency. Situation shows importance of sticking to science-based decisions, former FDA officials say.
People In Brief
NPA’s former exec director joins CHPA; Henderson heads FDA’s women’s health office on permanent basis; Nestle promotes nutrition exec Goodyear; Bayer vet Lowinski leads Sanofi’s Asia region; more People In Brief.
People In Brief
NPA’s former exec director joins CHPA; Henderson heads FDA’s women’s health office on permanent basis; Nestle promotes nutrition exec Goodyear; Bayer vet Lowinski leads Sanofi’s Asia region; more People In Brief.